XORTX Announces Positive Topline Results from Part 2 Pharmacokinetics Bridging Study
22.08.2022 - Clinical Trial Shows Substantially Increased Bioavailability with Food and a Clean Safety and Pharmacologic ProfileCALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) - XORTX Therapeutics Inc. ('XORTX' or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | ... Seite 1